AI Platform Drives Rare Disease Revenue With HCP Targeting
Download PDF
AI platform for life sciences accelerates rare disease care—identifying 11 key HCPs, initiating 3 patient treatments, and delivering $1.2M in revenue within 60 days.
OUR TASK
A large global biopharma client needed to revamp their outdated HCP list, uncover untapped patient opportunities, and meet ambitious sales goals despite limited resources and rare disease prevalence. Using AI platform AnswerY, our outsourced remote sales team identified high-value HCPs, enabled faster diagnoses, and the potential to hit $3.5M+ in revenue.
Download PDF
The Power of This Partnership
$1.2M
Rare Disease Revenue In 60 Days
The Ask
CLIENT
Global
Large BioPharma
Update HCP Targeting List, Stat
Address outdated targeting strategies by tackling challenges stemming from a 2-year-old HCP list that limited visibility into new patient opportunities.
Uncover High-Value Prescribers
Identify key decision-making HCPs treating patients with rare diseases to accelerate the adoption and uptake of targeted therapies for better patient outcomes.
Do More With Less
Tackle challenges like limited resources, low prioritization of the therapy, and a small field team.
Tackle Lofty Sales Goals
Support aggressive sales targets despite limited resources and the inherent challenges of working within the rare disease market’s small patient populations.
The Approach
TOOLS
AnswerY
Remote Team
Patient Finding
Build A Precision HCP List
Develop a precision-targeted HCP list using the AI biopharma platform AnswerY to ensure outreach focuses on the most impactful healthcare providers.
Find Hidden High-Impact HCPs
Deploy outsourced remote sales team to identify overlooked, high-impact HCPs who are not easily found through traditional claims data, creating new patient opportunities.
Get Actionable AI Insights Fast
Leverage real-time AI insights and AnswerY’s 30-day data lag to uncover faster, actionable opportunities for HCPs and field teams.
Turn Awareness Into Prescriptions
Drive awareness through focused outreach by educating HCPs about the disease state and targeted therapy, converting unaware providers into active prescribers.
Partner For Faster Patient Care
Collaborate with field reps to ensure the swift identification of patients and rapid treatment initiation, maximizing the benefit for both the client and patients.
The Results
OUTCOME
Rare Patients Identified
Revenue Growth
AI-Powered Intel
11 High-Value HCPs Identified
Amplity’s outsourced remote sales team pinpointed key healthcare providers managing patients with rare diseases, including 3 with immediate treatment potential and 8 ready to refer.
$1.2M Revenue In 60 Days
Delivered immediate ROI through hyper-targeted outreach, with long-term revenue potential exceeding $3.5M.
Validated AI Platform Success
Proved the impact of AnswerY by uncovering actionable opportunities and optimizing rare disease market strategies.
Transformed Outreach Strategy
Shifted from traditional methods to precision-targeted, AI-driven approaches, enabling the field team to achieve more with limited resources.
